From Bell Biotech Snippets from RBS "Near term milestones to watch * Tissue Therapies (TIS) - 2QCY11 - Sign licensing deal with large wound-care company. "Is this an old target or the 1QCY11 confused? Or is it something i've missed somewhere?
I88 Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”
RNU Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
TLX Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
